Abstract: A shipping system comprises an article of furniture and a packaging assembly. The packaging assembly includes a container and a protective insert. The container houses the article of furniture. The protective insert is disposed within the container and is positioned to help protect the article of furniture from damage. The protective insert has at least one convertible portion that is adapted to be removed from a surrounding portion of the protective insert, transition between a first configuration and a second configuration, and form at least a portion of an accessory product for the article of furniture when the convertible portion is in the second configuration.

Abstract: A building management system for one or more buildings, having a processor and a display for showing a model of a building being managed. The model may be shown as a three dimensional depiction or rendition, or a virtual building. A database may provide information regarding sensors, actuators and other items which may be viewed in conjunction with the displayed model. Information regarding the location and status of the sensors, control devices, and the like, which may be points of interest, may be mapped on the virtual depiction or model of the building. A user or operator may thus move through the building and view and affect rooms, sensing and control devices, and other items, including quick navigation to points of interest, in virtual reality. A recorder and play mechanism may be a significant portion of the system for recording structures, parameters, environment, events and other information of the system.

Abstract: A building management system for one or more buildings, having a processor and a display for showing a model of a building being managed. The model may be shown as a three dimensional depiction or rendition, or a virtual building. A database may provide information regarding sensors, actuators and other items which may be viewed in conjunction with the displayed model. Information regarding the location and status of the sensors, control devices, and the like, which may be points of interest, may be mapped on the virtual depiction or model of the building. A user or operator may thus move through the building and view and affect rooms, sensing and control devices, and other items, including quick navigation to points of interest, in virtual reality. A recorder and play mechanism may be a significant portion of the system for recording structures, parameters, environment, events and other information of the system.

Abstract: It has been discovered that certain phosphoinositides demonstrate antibacterial activity. Particularly, these phosphoinositides have been discovered to prevent the adhesion of H. influenzae onto the nasopharyngeal cells of mammals, and, in particular, humans. Phosphoinositides useful with the present invention have the following formula: wherein R1 and R2 are selected from the group consisting of hydrogen and monounsaturated and saturated fatty acids having a carbon chain length of C6 to C20 and R1 and R2 can be the same or different; and R3 to R7 are selected from the group consisting of hydrogen or a phosphate moiety with at least two of R3 to R7 being a phosphate moiety; and hydrates and pharmaceutically acceptable salts thereof.

Abstract: It has been discovered that certain phosphoinositides demonstrate antibacterial activity. Particularly, these phosphoinositides have been discovered to prevent the adhesion of H. influenzae onto the nasopharyngeal cells of mammals, and, in particular, humans.

Abstract: It has been discovered that certain phosphoinositides demonstrate antibacterial activity. Particularly, these phosphoinositides have been discovered to prevent the adhesion of H. influenzae onto the nasopharyngeal cells of mammals, and, in particular, humans. Phosphoinositides useful with the present invention have the following formula: wherein R1 and R2 are selected from the group consisting of hydrogen and monounsaturated and saturated fatty acids having a carbon chain length of C6 to C20 and R1 and R2 can be the same or different; and R3 to R7 are selected from the group consisting of hydrogen or a phosphate moiety with at least two of R3 to R7 being a phosphate moiety; and hydrates and pharmaceutically acceptable salts thereof.

Abstract: The present invention is directed to a rice flour extract (RFE) which can be used in the prophylaxis and treatment of bacterial infections, particularly bacterial infections caused by Haemophilus influenzae and to a method of preparing and using such an antibacterial rice flour extract. The anti-Haemophilus influenzae rice flour extract of the present invention can be prepared from commercial food grade rice flours or non-commercial food grade rice flours.

Abstract: A method of treating pneumonia or other respiratory disease caused by respiratory syncytial virus, adenovirus, parainfluenza virus, or influenza virus by orally administering a liquid, preferably an infant formula, containing a virus neutralizing antibody.

Abstract: The attachment of H. influenzae to human cells, such as oropharyngeal cells, may be inhibited by native human .beta.-casein, a recombinant form of human .beta.-casein, and hydrolysates of both. The human .beta.-casein or hydrolysate may be contained in a liquid enteral nutritional product such as an infant formula. The enteral nutritional product may be used, for example, in the prevention and treatment of otitis media in infants. The human .beta.-casein or hydrolysate may also be administered as a throat spray or nasally using drops or a spray.

Abstract: A method is provided for inhibiting rotavirus infection of human cells by treating the rotavirus with a carrageenan. The most effective agent in inhibiting cellular rotavirus infection is lambda-carrageenan, which may be formulated in a liquid and ingested enterally. A composition containing lambda-carrageenan is an aspect of the invention.

Abstract: The attachment of H. influenzae to human cells, such as oropharyngeal cells, may be inhibited by native human .beta.-casein, a recombinant form of human .beta.-casein, and hydrolysates of both. The human .beta.-casein or hydrolysate may be contained in a liquid enteral nutritional product such as an infant formula. The enteral nutritional product may be used, for example, in the prevention and treatment of otitis media in infants. The human .beta.-casein or hydrolysate may also be administered as a throat spray or nasally using drops or a spray.